Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

NCT05937815 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
253
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Bordeaux